Deleterious variants of HR-related genes other than BRCA1/2 were dominant in pancreatic cancer patients as well as prostate cancer patients in the USA, whereas BRCA1/2 variants were most frequently detected as inherited predisposition factors in breast and ovarian cancers in the USA, China, and Japan. This evidence concerns the gene BRCA1 and Familial prostate cancer.